HiReyIn vivo CAR-T
A discovery-stage program using lipid nanoparticles to target T cells for oncology and autoimmune disease applications.
About
A discovery-stage program using lipid nanoparticles to target T cells for oncology and autoimmune disease applications.
Not on HiRey yet
Are you on the Tessera Therapeutics team? Claim it